Charles River Laboratories International Inc (CRL):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Charles River Laboratories International Inc (CRL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7159
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:62
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Charles River Laboratories International Inc (Charles River) is a contract research organization (CRO) that provides essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. The organization also offers clinical, manufacturing and operations and staffing support. It focuses on providing solutions targeted against therapeutic areas of cardiovascular, central nervous system, metabolic inflammation, oncology, ophthalmology, respiratory disease and musculoskeletal disease. Charles River caters its products and services to pharmaceutical and biotechnology companies, government agencies, as well as leading hospitals and academic institutions. It operates through its network facilities located worldwide. Charles River is headquartered in Wilmington, Massachusetts, the US.

Charles River Laboratories International Inc (CRL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Charles River Laboratories International Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Charles River Laboratories International Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Charles River Laboratories International Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Charles River Laboratories International Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Charles River Laboratories International Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Charles River Laboratories International Inc, Medical Equipment, Deal Details 12
Partnerships 12
Charles River Lab Enters into Licensing Agreement with ERS Genomics 12
InSphero to Enter into Licensing Agreement with Charles River Labs 13
SenzaGen Enters into Distribution Agreement with Charles River Laboratories 14
Charles River Labs Expands Agreement with OcellO 15
Charles River and PathoQuest Expand Biologics Partnership 16
Molecular Imaging Enters into Co-Promotion Agreement with Oncotest 17
BioFocus Extends Agreement With Michael J. Fox Foundation For Parkinson’s Disease 18
Charles River Labs Enters Into Agreement With Bruker For Axcess System 19
Reinnervate Enters Into Co-Marketing Agreement With Oncotest For Alvetex Scaffold Technology 20
Equity Offering 21
Charles River Laboratories International Plans to Raise Funds in Public Offering of Securities 21
Debt Offering 22
Charles River Lab Raises USD500 Million in Private Placement of 5.5% Senior Notes Due 2026 22
Asset Transactions 23
AAIPharma Services Acquires Celsis Analytical Services From Celsis International 23
Acquisition 24
Charles River Laboratories Acquires MPI Research for USD800 Million 24
Charles River Labs Acquires Celsis International for USD214.5 Million 26
MPI Research Acquired Jasper Clinic, Clinical Research Organization 27
Charles River Labs Acquires Accugenix, Provider Of Microbe Identification Services, For USD18.4 Million 28
Charles River Laboratories International Inc – Key Competitors 29
Charles River Laboratories International Inc – Key Employees 30
Charles River Laboratories International Inc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 36
Strategy And Business Planning 36
Jun 19, 2018: Charles River Laboratories Joins UConn TIP 36
Financial Announcements 37
Aug 08, 2018: Charles River Laboratories announces second-quarter 2018 results from continuing operations 37
May 10, 2018: Charles River Laboratories Announces First-Quarter 2018 Results from Continuing Operations 39
Feb 13, 2018: Charles River Laboratories Announces Fourth-Quarter 2017 Financial Results 41
Nov 09, 2017: Charles River Laboratories Announces Third-Quarter 2017 Results from Continuing Operations 44
Aug 09, 2017: Charles River Laboratories Announces Second-Quarter 2017 Results from Continuing Operations 46
May 10, 2017: Charles River Laboratories Announces First-Quarter 2017 Results from Continuing Operations 48
Feb 14, 2017: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2016 Results from Continuing Operations and Provides 2017 Guidance 50
Corporate Communications 53
Feb 13, 2018: Charles River Laboratories Announces Executive Management Appointments 53
Jan 16, 2018: Charles River Laboratories Adds Jean-Paul Mangeolle to Board of Directors 54
Jul 05, 2017: Charles River Laboratories Adds Martin Mackay, Ph.D. to Board of Directors 55
Product News 56
Nov 01, 2017: Charles River Laboratories Presents Newly Expanded Capabilities at Neuroscience 2017 56
Other Significant Developments 58
Mar 08, 2018: Charles River Laboratories Makes Expansions to Global Biologics Infrastructure 58
Dec 06, 2017: Charles River Adds ERS License to CRISPR/Cas9 Service Offering 59
Jun 28, 2017: SenzaGen signs global distribution agreement with Charles River Laboratories 60
May 16, 2017: Charles River Laboratories Announces Updates to Oncology Business 61
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62

List of Tables
Charles River Laboratories International Inc, Medical Equipment, Key Facts, 2017 2
Charles River Laboratories International Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Charles River Laboratories International Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Charles River Laboratories International Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Charles River Laboratories International Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Charles River Laboratories International Inc, Deals By Market, 2012 to YTD 2018 9
Charles River Laboratories International Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Charles River Lab Enters into Licensing Agreement with ERS Genomics 12
InSphero to Enter into Licensing Agreement with Charles River Labs 13
SenzaGen Enters into Distribution Agreement with Charles River Laboratories 14
Charles River Labs Expands Agreement with OcellO 15
Charles River and PathoQuest Expand Biologics Partnership 16
Molecular Imaging Enters into Co-Promotion Agreement with Oncotest 17
BioFocus Extends Agreement With Michael J. Fox Foundation For Parkinson's Disease 18
Charles River Labs Enters Into Agreement With Bruker For Axcess System 19
Reinnervate Enters Into Co-Marketing Agreement With Oncotest For Alvetex Scaffold Technology 20
Charles River Laboratories International Plans to Raise Funds in Public Offering of Securities 21
Charles River Lab Raises USD500 Million in Private Placement of 5.5% Senior Notes Due 2026 22
AAIPharma Services Acquires Celsis Analytical Services From Celsis International 23
Charles River Laboratories Acquires MPI Research for USD800 Million 24
Charles River Labs Acquires Celsis International for USD214.5 Million 26
MPI Research Acquired Jasper Clinic, Clinical Research Organization 27
Charles River Labs Acquires Accugenix, Provider Of Microbe Identification Services, For USD18.4 Million 28
Charles River Laboratories International Inc, Key Competitors 29
Charles River Laboratories International Inc, Key Employees 30
Charles River Laboratories International Inc, Subsidiaries 32

List of Figures
Charles River Laboratories International Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Charles River Laboratories International Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Charles River Laboratories International Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Charles River Laboratories International Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Charles River Laboratories International Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Charles River Laboratories International Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Charles River Laboratories International Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Charles River Laboratories International Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Charles River Laboratories International Inc (CRL):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Censo Biotechnologies Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Censo Biotechnologies Ltd (Censo) formerly Roslin Cellab Limited, a subsidiary of Roslin Foundation, is a provider of human cells and contract research services for drug discovery, toxicity testing and cell banking. The company offers iPSC services; differentiated cell types; in vitro assays …
  • Proteon Therapeutics Inc (PRTO):製薬・医療:M&Aディール及び事業提携情報
    Summary Proteon Therapeutics Inc (Proteon Therapeutics) is a late-stage biopharmaceutical company that develops pharmaceutical products for the treatment of renal and vascular diseases. The company develops investigational therapies to treat hemodialysis and peripheral artery disease patients. Its p …
  • Baxter International Inc.:企業のM&A・事業提携・投資動向
    Baxter International Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Baxter International Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Kuwait Food Company (Americana) KSCP:企業の戦略的SWOT分析
    Kuwait Food Company (Americana) KSCP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • McWane, Inc.:企業の戦略・SWOT・財務分析
    McWane, Inc. - Strategy, SWOT and Corporate Finance Report Summary McWane, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Ws Atkins Ltd:企業の戦略・SWOT・財務分析
    Ws Atkins Ltd - Strategy, SWOT and Corporate Finance Report Summary Ws Atkins Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Bombardier Inc:企業の戦略・SWOT・財務情報
    Bombardier Inc - Strategy, SWOT and Corporate Finance Report Summary Bombardier Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Athera Biotechnologies AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Athera Biotechnologies AB (Athera) is a clinical stage biopharmaceutical company that focuses on the development of anti-inflammatory biological candidate drugs for the prevention and treatment of immunovascular disease. The company develops a proprietary clinical development stage program, …
  • HSH Nordbank Private Banking:企業の戦略・SWOT・財務情報
    HSH Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report Summary HSH Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Aeroport Anapa:企業の戦略・SWOT・財務分析
    Aeroport Anapa - Strategy, SWOT and Corporate Finance Report Summary Aeroport Anapa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • PT Kimia Farma (Persero) Tbk (KAEF):製薬・医療:M&Aディール及び事業提携情報
    Summary PT Kimia Farma (Persero) Tbk (Kimia Farma) manufactures, commercializes and distributes pharmaceutical products. The company provides ethical (prescription), generic and other products. It offers products in various categories including alimentary system, allergy and immune system, system an …
  • Voltalia SA (VLTSA):企業の財務・戦略的SWOT分析
    Voltalia SA (VLTSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Asian Citrus Holdings Ltd. (73):企業の財務・戦略的SWOT分析
    Asian Citrus Holdings Ltd. (73) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Oncolytics Biotech Inc (ONC):医療機器:M&Aディール及び事業提携情報
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is indicated for the treatment of l …
  • Screen Holdings Co., Ltd. (7735):企業の財務・戦略的SWOT分析
    Screen Holdings Co., Ltd. (7735) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Vilniaus Degtine AB:企業の戦略・SWOT・財務分析
    Vilniaus Degtine AB - Strategy, SWOT and Corporate Finance Report Summary Vilniaus Degtine AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Renco Group SpA:企業の戦略的SWOT分析
    Renco Group SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Aurora Health Care Inc:企業の戦略的SWOT分析
    Aurora Health Care Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Takara Holdings Inc.:企業の戦略・SWOT・財務分析
    Takara Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Takara Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Kangwon Land Inc.:企業の戦略・SWOT・財務分析
    Kangwon Land Inc. - Strategy, SWOT and Corporate Finance Report Summary Kangwon Land Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆